Skin infections in IV drug users

Author: Dr Amy Stanway MBChB, Registrar, Department of Dermatology, Waikato Hospital, Hamilton, New Zealand, 2002.

Skin and soft tissue bacterial infections are a common complication of intravenous drug use. This high rate is due to:

Clinical Features

Although skin infections usually present as areas of redness, warmth and tenderness (inflammation), the appearance in intravenous drug users is often atypical. This is because the skin, venous and lymphatic systems are damaged by the frequent penetration of the skin and consequent low-grade infection.

The results are:

Fever may or may not be present but bloodstream infection (septicaemia) is uncommon, unless the individual is immune suppressed (e.g. HIV infection).

Infections usually affect the arms or legs as these are the sites used most frequently for injection. Unusual sites may be involved (eg. abdomen, back, groin, scrotum and neck) due to injections in the jugular (neck) or femoral (groin) veins.

Abscess Cellulitis Necrotising fasciitis
Abscess Cellulitis Necrotising fasciitis
Serious skin infections

Types of Infection

Cellulitis is usually caused by Group A streptococci or Staphylococcus aureus.

Abscesses are collections of pus. They are usually caused by infection with Staphylococcus aureus but in drug users they occasionally contain a mixture of aerobic bacteria (that require oxygen) and anaerobic bacteria (that do not require oxygen). These mixed abscesses often result in a foul odour.

Skin ulcers
Skin ulcers are common in intravenous drug users. They are generally shallow but have hardened edges. The ulcers are thought to arise from a combination of inflammation around foreign bodies (ie. material from injected drugs) and infection. They can heal with good wound care and oral antibiotics but occasionally require skin grafting.

Necrotising Fasciitis
Necrotising fasciitis is a rare but life-threatening complication of intravenous drug use. In drug users, it most frequently affects an injection site on the left arm. It presents as an area of cellulitis i.e. red, swollen, tender skin with a fever. However the affected area is exquisitely painful and tender and the patient is much sicker and may collapse in shock. There may be crepitus: this is a crackling, popping sensation under the skin due to gas in the soft tissues.

Necrotising fasciitis in drug users may be caused by a variety of bacteria including Staphylococcus aureus, aerobic and anaerobic streptococci, Gram-negative bacilli from the gut and other anaerobes.

Management involves immediate surgical exploration of the tissue to drain the pus and remove all the dead skin. Broad spectrum antibiotics such as amoxicillin with clavulanic acid or a combination of vancomycin or flucloxacillin and metronidazole and an aminoglycoside are required.

Necrotising fasciitis in intravenous drug users is less likely to result in death or amputation than in non-drug users. The better outcome may be because it affects less dangerous sites (ie. limbs versus buttocks and trunk) or because the patients are generally younger and are less likely to suffer from a predisposing illness such as diabetes.

Septic thrombophlebitis
Septic thrombophlebitis is an infected blood clot in a vein, which may be life-threatening. The effects of septic thrombophlebitis may include:

Treatment is with intravenous antibiotics. These should be broad-spectrum until cultures confirm the causative organism(s). If possible, the affected vein should be tied off and removed surgically.

Miscellaneous Infections Much rarer infectious complications of intravenous drug use that have characteristic skin findings include:

Related topics

On DermNet NZ:

Email Newsletter

Would you like to receive our dermatology updates by email?


Submit your images

We're seeking high-quality photos of skin diseases.  


Machine diagnosis

Watch DermNet's proposal to create a 'Skin Disease Image Recognition Tool' - winner of the 2017 'Clinicians' Challenge Active Award' by the NZ Ministry of Health and HiNZ.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter